...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats.
【24h】

Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats.

机译:血管紧张素II 1型受体反义寡核苷酸对自发性高血压大鼠肾功能的差异作用。

获取原文
获取原文并翻译 | 示例

摘要

The effect of selectively decreasing renal angiotensin II type 1 (AT1) receptor expression on renal function and blood pressure has not been determined. Therefore, we studied the consequences of selective renal inhibition of AT1 receptor expression in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) in vivo. Vehicle, AT1 receptor antisense oligodeoxynucleotides (AS-ODN), or scrambled oligodeoxynucleotides were infused chronically into the cortex of the remaining kidney of conscious, uninephrectomized WKY and SHR on a 4% NaCl intake. Basal renal cortical membrane AT1 receptor protein was greater in SHR than in WKY. In WKY and SHR, AS-ODN decreased renal but not cardiac AT1 receptors. AT1 receptor AS-ODN treatment increased plasma renin activity to a greater extent in WKY than in SHR. However, plasma angiotensin II and aldosterone were increased by AS-ODN to a similar degree in both rat strains. In SHR, sodium excretion was increased and sodium balance was decreased by AS-ODN but had only a transient ameliorating effect on blood pressure. Urinary protein and glomerular sclerosis were markedly reduced by AS-ODN-treated SHR. In WKY, AS-ODN had no effect on sodium excretion, blood pressure, or renal histology but also modestly decreased proteinuria. The major consequence of decreasing renal AT1 receptor protein in the SHR is a decrease in proteinuria, probably as a result of the amelioration in glomerular pathology but independent of systemic blood pressure and circulating angiotensin II levels.
机译:尚未确定选择性降低1型肾血管紧张素II(AT1)受体表达对肾功能和血压的影响。因此,我们研究了正常血压的Wistar-Kyoto大鼠(WKY)和自发性高血压大鼠(SHR)在体内选择性肾抑制AT1受体表达的后果。将载剂,AT1受体反义寡脱氧核苷酸(AS-ODN)或加扰的寡脱氧核苷酸以4%NaCl摄入量长期注入有意识的,未切除血常规的WKY和SHR的其余肾脏皮质中。在SHR中,基础肾皮质膜AT1受体蛋白比WKY中的大。在WKY和SHR中,AS-ODN降低了肾脏,但没有降低心脏AT1受体。 AT1受体AS-ODN治疗在WKY中的血浆肾素活性增加幅度大于SHR。但是,在两种大鼠品系中,AS-ODN都会使血浆血管紧张素II和醛固酮水平升高。在SHR中,通过AS-ODN可以增加钠排泄,减少钠平衡,但对血压只有短暂的改善作用。 AS-ODN治疗的SHR可显着降低尿蛋白和肾小球硬化。在WKY中,AS-ODN对钠排泄,血压或肾脏组织学无影响,但也可适度降低蛋白尿。 SHR中肾AT1受体蛋白减少的主要结果是蛋白尿的减少,这可能是肾小球病理改善的结果,但与全身血压和循环血管紧张素II水平无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号